Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response.
During infection, parasites evade the host immune system by modulating or exploiting the immune system; e.g., they suppress expression of major histocompatibility complex class II molecules or secrete cytokine-like molecules. However, it is not clear whether helminths disturb the immune responses of their hosts by controlling the antigen-processing pathways of the hosts. In this study, we identified a new cysteine protease inhibitor, nippocystatin, derived from excretory-secretory (ES) products of an intestinal nematode, Nippostrongylus brasiliensis. Nippocystatin, which belongs to cystatin family 2, consists of 144 amino acids and is secreted as a 14-kDa mature form. In vivo treatment of ovalbumin (OVA)-immunized mice with recombinant nippocystatin (rNbCys) profoundly suppressed OVA-specific proliferation of splenocytes but not non-antigen-specific proliferation of splenocytes. OVA-specific cytokine production was also greatly suppressed in rNbCys-treated mice. Although the serum levels of both OVA-specific immunoglobulin G1 (IgG1) and IgG2a were not affected by rNbCys treatment, OVA-specific IgE was preferentially downregulated in rNbCys-treated mice. In vitro rNbCys inhibited processing of OVA by lysosomal cysteine proteases from the spleens of mice. Mice with anti-nippocystatin antibodies became partially resistant to infection with N. brasiliensis. Based on these findings, N. brasiliensis appears to skillfully evade host immune systems by secreting nippocystatin, which modulates antigen processing in antigen-presenting cells of hosts.
Dainichi
T
T
Department of Parasitology and Immunology, The University of Tokushima School of Medicine, Tokushima, Japan. dainichi@dermatol.med.kyushu-u.ac.jp
Maekawa
Y
Y
Ishii
K
K
Zhang
T
T
Nashed
B F
BF
Sakai
T
T
Takashima
M
M
Himeno
K
K
D000595:Amino Acid Sequence; D000818:Animals; D000918:Antibody Specificity; D017951:Antigen Presentation / Q000187:drug effects*; D000947:Antigens, Helminth / Q000276:immunology*; D015891:Cystatins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D015853:Cysteine Proteinase Inhibitors / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009559:Nippostrongylus / Q000276:immunology*; D010047:Ovalbumin / Q000276:immunology; D017386:Sequence Homology, Amino Acid; D013154:Spleen / Q000166:cytology / Q000276:immunology; D017206:Strongylida Infections / Q000276:immunology
D000947:Antigens, Helminth; D015891:Cystatins; D015853:Cysteine Proteinase Inhibitors; C426409:nbcys protein, Nippostrongylus brasiliensis; D010047:Ovalbumin